Treatment strategies for protein-losing enteropathy in Fontan-palliated patients.
Anastasia SchleigerStanislav OvroutskiBjörn PetersStephan SchubertJoachim PhotiadisFelix BergerPeter KramerPublished in: Cardiology in the young (2020)
Protein-losing enteropathy is a serious condition limiting survival after the Fontan procedure. Comprehensive assessment and individual treatment strategies are mandatory to achieve best possible outcome. Nevertheless, relapse is frequent and long-term mortality substantial. Cardiac transplantation should be considered early as treatment option.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- protein protein
- prognostic factors
- left ventricular
- cardiovascular events
- stem cells
- type diabetes
- binding protein
- minimally invasive
- small molecule
- risk factors
- cardiovascular disease
- patient reported outcomes
- combination therapy
- replacement therapy